These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8930481)

  • 21. Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.
    Patel K; Panchasara A; Purohit B; Tripathi CB
    Curr Drug Saf; 2013 Feb; 8(1):72-4. PubMed ID: 23656450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.
    Paquet P; Jacob E; Damas P; Piérard GE
    Burns; 2001 Sep; 27(6):652-5. PubMed ID: 11525863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal toxic epidermal necrolysis associated with co-trimoxazole.
    Carmichael AJ; Tan CY
    Lancet; 1989 Sep; 2(8666):808-9. PubMed ID: 2571053
    [No Abstract]   [Full Text] [Related]  

  • 24. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms.
    Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P
    Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.
    Belfort R; de Smet M; Whitcup SM; Pavesio C; Lottenberg C; Rubin B; Lopez JS; Nussenblatt R
    Cornea; 1991 Nov; 10(6):536-8. PubMed ID: 1782783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfonamide Hypersensitivity: Fact and Fiction.
    Khan DA; Knowles SR; Shear NH
    J Allergy Clin Immunol Pract; 2019; 7(7):2116-2123. PubMed ID: 31495421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidermal necrolysis linked to the dermal application of a potassium hydroxide solution].
    Korsaga-Somé N; Tapsoba P; Ouédraogo MS; Ilboudo LB; Barro-Traoré F; Niamba P; Traoré A
    Pan Afr Med J; 2015; 21():299. PubMed ID: 26587148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis.
    Baird BJ; De Villez RL
    Int J Dermatol; 1988 Apr; 27(3):170-4. PubMed ID: 3286546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concidence of cotrimoxazole induced toxic epidermal necrolysis and chronic Q Fever in an Afghan shepherd.
    Didona D; Cunha T; Viti G; Juratli HA; Hertl M
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):e939-e940. PubMed ID: 35789041
    [No Abstract]   [Full Text] [Related]  

  • 31. Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole.
    Tabet Aoul A; Al-Nasseri A; Hall C; He C; Abernathy J
    Am J Case Rep; 2024 Jan; 25():e942982. PubMed ID: 38247161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe hypoglycemia associated with trimethoprim-sulfamethoxazole therapy.
    McKnight JT; Gaskins SE; Pieroni RE; Machen GM
    J Am Board Fam Pract; 1988; 1(2):143-5. PubMed ID: 3261928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Wolkenstein P; Carrière V; Charue D; Bastuji-Garin S; Revuz J; Roujeau JC; Beaune P; Bagot M
    Pharmacogenetics; 1995 Aug; 5(4):255-8. PubMed ID: 8528274
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic toxicity associated with trimethoprim-sulfamethoxazole: report of a case.
    Bartlett JC; Park H; Moe R
    J Am Osteopath Assoc; 1985 Jun; 85(6):381-2. PubMed ID: 3877712
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
    Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC
    J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological skin covers in treatment of two cases of the Lyell's syndrome.
    Klein L; Mĕricka P; Straková H; Jebavý L; Nozicková M; Bláha M; Talábová Z; Hosek F
    Ann Transplant; 1997; 2(1):45-8. PubMed ID: 9869841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A suspected case of trimethoprim-sulfamethoxazole-induced loss of fingernails and toenails.
    Slaughenhoupt BL; Adeagbo S; Van Savage JG
    Pediatr Infect Dis J; 1999 Jan; 18(1):76-7. PubMed ID: 9951991
    [No Abstract]   [Full Text] [Related]  

  • 39. Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis.
    Haas EJ
    JAMA; 1984 Jul; 252(3):346. PubMed ID: 6610773
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
    McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
    Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.